首页> 外文期刊>Journal of neuroinflammation >Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays
【24h】

Aquaporin-4 autoantibodies in neuromyelitis optica spectrum disorders: comparison between tissue-based and cell-based indirect immunofluorescence assays

机译:Aquaporin-4自身抗体在视神经脊髓炎频谱疾病中的应用:基于组织的间接免疫荧光检测与基于细胞的间接免疫荧光检测的比较

获取原文
           

摘要

Background Neuromyelitis optica spectrum disorders (NMOSD) are severe central nervous system inflammatory demyelinating disorders (CNS IDD) characterized by monophasic or relapsing, longitudinally extensive transverse myelitis (LETM) and/or optic neuritis (ON). A significant proportion of NMOSD patients are seropositive for aquaporin-4 (AQP4) autoantibodies. We compared the AQP4 autoantibody detection rates of tissue-based indirect immunofluorescence assay (IIFA) and cell-based IIFA. Methods Serum of Chinese CNS IDD patients were assayed for AQP4 autoantibodies by tissue-based IIFA using monkey cerebellum and cell-based IIFA using transfected HEK293 cells which express human AQP4 on their cell membranes. Results In total, 128 CNS IDD patients were studied. We found that 78% of NMO patients were seropositive for AQP4 autoantibodies by cell-based IIFA versus 61% by tissue-based IFA (p = 0.250), 75% of patients having relapsing myelitis (RM) with LETM were seropositive by cell-based IIFA versus 50% by tissue-based IIFA (p = 0.250), and 33% of relapsing ON patients were seropositive by cell-based IIFA versus 22% by tissue-based IIFA (p = 1.000); however the differences were not statistically significant. All patients seropositive by tissue-based IIFA were also seropositive for AQP4 autoantibodies by cell-based IIFA. Among 29 NMOSD patients seropositive for AQP4 autoantibodies by cell-based IIFA, 20 (69%) were seropositive by tissue-based IIFA. The 9 patients seropositive by cell-based IIFA while seronegative by tissue-based IIFA had NMO (3), RM with LETM (3), a single attack of LETM (1), relapsing ON (1) and a single ON attack (1). Among 23 NMO or RM patients seropositive for AQP4 autoantibodies by cell-based IIFA, comparison between those seropositive (n = 17) and seronegative (n = 6) by tissue-based IIFA revealed no differences in clinical and neuroradiological characteristics between the two groups. Conclusion Cell-based IIFA is slightly more sensitive than tissue-based IIFA in detection of AQP4 autoantibodies, which are highly specific for NMOSD.
机译:背景技术神经脊髓炎视神经频谱疾病(NMOSD)是严重的中枢神经系统炎性脱髓鞘疾病(CNS IDD),其特征为单相或复发性,纵向广泛性横贯性脊髓炎(LETM)和/或视神经炎(ON)。 NMOSD患者中很大一部分对aquaporin-4(AQP4)自身抗体呈血清反应阳性。我们比较了基于组织的间接免疫荧光测定法(IIFA)和基于细胞的IIFA的AQP4自身抗体检出率。方法采用猴小脑组织IIFA检测中国CNS IDD患者血清中AQP4自身抗体,转染HEK293细胞的人IIA细胞基于IIFA细胞中IIA检测AQP4自身抗体。结果共研究了128例CNS IDD患者。我们发现78%的NMO患者通过基于细胞的IIFA对AQP4自身抗体呈血清反应阳性,而对于基于组织的IFA则为61%(p = 0.250),患有LETM的复发性脊髓炎(RM)的患者对基于细胞的IITM具有血清阳性IIFA对比基于组织的IIFA占50%(p = 0.250),基于细胞的IIFA复发的ON患者中有33%呈血清阳性,而基于组织的IIFA则为22%(p = 1.000);但是差异没有统计学意义。所有基于组织的IIFA血清反应阳性的患者,对于基于细胞的IIFA的AQP4自身抗体也呈血清反应阳性。在29位基于细胞的IIFA对AQP4自身抗体呈血清反应阳性的NMOSD患者中,有20位(69%)对基于组织的IIFA呈血清反应阳性。基于细胞的IIFA血清反应阳性而基于组织的IIFA血清反应阴性的9例患者具有NMO(3),RM与LETM(3),LETM一次发作(1),复发ON(1)和一次ON发作(1) )。在23名通过细胞IIFA对AQP4自身抗体呈血清反应阳性的NMO或RM患者中,通过基于组织的IIFA对那些血清阳性(n = 17)和血清阴性(n = 6)的患者进行比较,发现两组之间在临床和神经放射学方面无差异。结论在检测对NMOSD具有高度特异性的AQP4自身抗体时,基于细胞的IIFA比基于组织的IIFA灵敏度更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号